Skip to main content

Table 1 Mean live Ixodes scapularis counts and efficacy relative to placebo at 8 h after treatment and post-treatment re-infestations for dogs treated with a single oral dose of sarolaner or afoxolaner on Day 0

From: Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard®) against induced infestations of Ixodes scapularis on dogs

Treatment

 

Day of treatment or re-infestation

 

0

7

14

21

28

35

Placebo

Range

20–40

12–32

17–37

18–40

12–32

15–34

A. mean

30.3

25.5

25.4

28.6

24.1

23.8

G. mean1

29.4a

24.2a

24.5a

27.8a

23.2a

23.0a

Sarolaner

Range

15–25

11–24

10–30

13–36

16–35

13–36

A. mean

20.8

16.8

16.1

19.6

25.6

23.1

Efficacy (%)

31.4

34.3

36.5

31.4

0.0

2.6

G. mean1

20.5b

16.2b

15.2b

18.5b

25.0a

21.9a

Efficacy (%)

30.3

32.8

38.0

33.5

0.0

5.0

P-value vs. placebo

0.0082

0.0174

0.0070

0.0065

0.5822

0.6940

Afoxolaner

Range

12–27

12–27

11–26

17–36

15–34

17–25

A. mean

18.4

21.8

17.6

23.3

23.6

20.0

Efficacy (%)

39.3

14.7

30.5

18.8

2.1

15.8

G. mean1

17.8b

21.1a,b

17.0b

22.7a,b

22.7a

19.9a

Efficacy (%)

39.6

12.5

30.8

18.5

1.9

13.8

P-value vs. placebo

0.0006

0.3909

0.0309

0.1445

0.8889

0.2619

P-value vs. sarolaner

0.2569

0.1028

0.5023

0.1487

0.4914

0.4585

  1. 1Geometric means within columns with the same superscript are not significantly different (P > 0.05)